awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33381940-5A85ED01-BBBE-4622-9AAF-1CD734460911
Q33381940-5A85ED01-BBBE-4622-9AAF-1CD734460911
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33381940-5A85ED01-BBBE-4622-9AAF-1CD734460911
Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.
P2860
Q33381940-5A85ED01-BBBE-4622-9AAF-1CD734460911
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33381940-5A85ED01-BBBE-4622-9AAF-1CD734460911
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
370e9621636cb203e3877f30da8bff7ed908672f
P2860
Survival after recurrence of Ewing's sarcoma family of tumors.